As pharma turns away, parents of children with ultra-rare diseases step in to advance drug development. #rarediseases #genetherapy www.swissinfo.ch/eng/new-trea...

Ageing is a major risk for many diseases but big pharma has invested very little in trying to understand what happens as we age. But this is changing as shown by the case of Novartis. #drugdiscovery #longevity #health #pharmaceuticals www.swissinfo.ch/eng/healthca...

With growing uncertainty in US financial markets and research funding, Chinese companies are swooping in to present themselves as stable, open partners to the Swiss #biotech sector. www.swissinfo.ch/eng/global-t...

No one would be talking about the potential of rapamycin for longevity if it weren't for the groundbreaking discovery by Michael Hall, a molecular biologist at the @biozentrum.unibas.ch, over 30 years ago. www.swissinfo.ch/eng/aging-so...

Rant mode [ON] Over the last 15 years, US cancer drug prices have doubled-from ~$100k to $200k per year. What do patients get for this extra $100k? Nada. Not better outcomes. Not more robust evidence. Just higher bills 🧵 academic.oup.com/healthaffair...

Huge advances in the science of #aging and tech have helped fuel a new #longevity movement. Clinics are popping up all over Switzerland and beyond offering diagnostic tests, novel therapies, and a world of promises. Are they just hype or the key to healthy aging? www.swissinfo.ch/eng/multinat...

European pharma hubs are getting the jitters as US tariffs loom large over the industry and more companies announce plans for big investments in the US. www.swissinfo.ch/eng/multinat...

People often mix up Switzerland and Sweden. But when it comes to cancer prevention and care there are some interesting differences. www.swissinfo.ch/eng/multinat...

Trump administration asks researchers working overseas on HIV and other diseases to disclose ties to those regarded as hostile, including “entities associated with communist, socialist or totalitarian parties." W/ @SherylNYT.bsky.social www.nytimes.com/2025/03/07/h...

Organizations funded by the United States helped keep dangerous pathogens in check around the world. Now many safeguards are gone, and Americans may pay the price. www.nytimes.com/2025/03/07/h...

Some 99% of NIH direct funding goes to US institutions but the NIH is still really important to scientists all over the world. Here’s why with perspective from Switzerland. www.swissinfo.ch/eng/science/...

Acute drug shortages may have eased in some countries since the end of the Covid pandemic but the underlying problems are still there and could get worse if tariffs disrupt global supply chains. www.swissinfo.ch/eng/multinat...

What's happening at #USAID is causing so much damage. The great reporters at @science.org explore some of that damage. www.science.org/content/arti...

The Trump administration's stop-work order on USAID left thousands of volunteers around the world w/ experimental drugs + medical devices in their bodies – cut off from care by researchers running clinical trials, in violation of the fundamental principles of research www.nytimes.com/2025/02/06/h...

Advertising of prescription drugs isn‘t allowed in Switzerland. But when does editorial content about the latest weight-loss drugs cross the line? #pharma #weightloss #medicine www.swissinfo.ch/eng/multinat...

Deaths from cancer continue to fall in the United States, the American Cancer Society reported, but within that encouraging trend is a disturbing shift in the cancer burden from older to younger adults and from men to women.

Terry Pirovolakis built a gene therapy to save his son from a rare disease. He has become the first stop and last hope for other desperate parents.